Skip to main content

natasha halasa Archives

Study finds most infants receiving ICU-level care for RSV had no underlying medical condition

Aug. 15, 2023—A Vanderbilt study found that most infants admitted to the intensive care or high acuity unit for respiratory syncytial virus (RSV) infections during fall 2022 were previously healthy and born at term.

Read more


High-dose flu vaccine beneficial for pediatric stem cell transplant patients

Mar. 2, 2023—Vanderbilt was the lead site for an influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population.

Read more


Event to spotlight VUMC’s COVID-19 research efforts

Nov. 3, 2022—The public is invited to listen in as scientists on the forefront of COVID-19 research at Vanderbilt University Medical Center share their personal stories on Wednesday afternoon, Nov. 16, in 214 Light Hall.

Read more


Study shows two vaccine doses for mothers eases COVID complications for infants

Jul. 6, 2022—Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

Read more


VUMC a national leader in physician-scientist training

Apr. 21, 2022—Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association.

Read more


Halasa, Jordan, Wilkins elected members of ASCI

Feb. 10, 2022—Three Vanderbilt faculty members have been elected this year to membership in the American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry.

Read more


Multisystem inflammatory syndrome in children (MIS-C) clinic opens at Monroe Carell Jr. Children’s Hospital at Vanderbilt

Apr. 20, 2021—Children who have experienced the rare and potentially life-threatening multisystem inflammatory syndrome in children (MIS-C), which can develop within four weeks of exposure to the virus that causes COVID-19, are being followed closely in a multidisciplinary clinic at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Read more


Study to track if COVID can spread during minimally invasive surgery

Aug. 27, 2020—Physician-scientists at Vanderbilt University Medical Center are investigating whether SARS-CoV-2, the virus that causes COVID-19, can be spread through aerosolized emissions (microscopic droplets and particles) during minimally invasive surgery in children.

Read more


New study examines coronavirus transmission within households

Jun. 30, 2020—Vanderbilt University Medical Center investigators are leading a new study that examines the transmission of SARS-CoV-2, the virus that causes COVID-19, within households in Nashville.

Read more


RSV transmission in the Middle East

Nov. 14, 2019—Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.

Read more


Vaccine study seeks to halt flu’s most severe side effects

Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.

Read more


IdeaShare initiative inspires wide variety of creative solutions

Jul. 13, 2017—Necessity is the mother of invention, so the saying goes.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more